COMPANY
SCA Pharmaceuticals
SCA Pharmaceuticals: 503B outsourcing facility, recalling firm for Oxytocin, Vancomycin, as stated by public registers.
503B OUTSOURCING FACILITY
Registered with FDA as a 503B outsourcing facility (compounding at scale).
| All products | Little Rock, AR, registered 2013-12-13 Regulator FDA 503B facility list |
|---|---|
| All products | Windsor, CT, registered 2017-08-03 Regulator FDA 503B facility list |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Oxytocin | Class III recall, Terminated, 2023-05-03 Regulator openFDA |
|---|---|
| Vancomycin | Class I recall, Terminated, 2017-04-12 Regulator openFDA |
| Vancomycin | Class II recall, Terminated, 2022-05-11 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.